Anesthetic considerations in a patient with Psoriasis undergoing CABG surgery
Journal of Cellular & Molecular Anesthesia,
Vol. 4 No. 2 (2019),
29 October 2019
,
Page 63-66
https://doi.org/10.22037/jcma.v4i2.27150
Abstract
A 51 years old man with a 30 years history of psoriasis was scheduled for elective CABG due to 3 vessels coronary artery involvement and the resulting ischemic heart diseases. The psoriatic lesions were on the limbs and posterior parts of the trunk. The perioperative period was eventless and the patient was under care in postoperative cardiac ICU ward. He was discharged home 10 days after the operation with stable psoriasis state.
- Psoriasis
- anesthesia
- CABG
- T cell
How to Cite
References
Baluch A, Kak A, Saleh O, Lonadier L, Kaye AD. Psoriasis and anesthetic considerations. Middle East journal of anaesthesiology. 2010;20(5):621-9.
Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. The British journal of dermatology. 2009;161(1):1-7.
Levine D, Gottlieb A. Evaluation and management of psoriasis: an internist's guide. The Medical clinics of North America. 2009;93(6):1291-303.
Raychaudhuri SP, Raychaudhuri SK. Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Progress in brain research. 2004;146:433-7.
Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. Journal of the European Academy of Dermatology and Venereology : JEADV. 2012;26 Suppl 2:3-11.
Mahajan R, Kumar Grover V. Neuraxial opioids and Koebner phenomenon: implications for anesthesiologists. Anesthesiology. 2003;99(1):229-30.
- Abstract Viewed: 401 times
- PDF Downloaded: 294 times